Aesthetic InfluenceLegal All documents

Customer agreements

Acceptable Use Policy

Practice Lab and 10K Consult · Aesthetic Influence, LLC

Version 1.0. Effective October 1, 2026.

This Acceptable Use Policy (this “Policy”) forms part of the Documentation referred to in the Master Software as a Service and Services Agreement (the “Master Agreement”) and is incorporated into it by Section 9.1 of that Agreement. It applies to every Customer, to every Authorized User, and to every person who accesses the Platform through credentials issued to a Customer.

Capitalized terms used but not defined in this Policy have the meanings given in the Master Agreement. Where this Policy conflicts with the Master Agreement, the Master Agreement governs. Where it conflicts with the Business Associate Agreement as to Protected Health Information, the Business Associate Agreement governs.

Aesthetic Influence may update this Policy in accordance with Section 2.4 and Section 9.1 of the Master Agreement. The version and effective date above identify the version in force. Prior versions are available on request.

TABLE OF CONTENTS

1. Purpose and Who This Policy Binds

2. General Obligations

3. Prohibited Content

4. Prohibited Conduct

5. Security, Credentials, and Systems

6. Protected Health Information and the Designated Perimeter

7. Patient Communications and Consent

8. Claims, Representations, and Patient-Facing Material

9. Artificial Intelligence Features

10. Records, Pipeline, and Reporting Integrity

11. The Member Community, Sessions, and Events

12. Competitively Sensitive Information

13. Competitive and Derivative Use

14. Third-Party Services and Integrations

15. Reporting a Concern

16. How We Enforce This Policy

17. No Duty to Monitor

18. Contact

1. Purpose and Who This Policy Binds

The Platform holds information about patients, about practices, and about the commercial terms on which practices do business. It also places competing practices in a shared community. This Policy states the conduct required of everyone who uses it, so that the Platform remains lawful, secure, and useful for every Customer.

Customer is responsible for compliance with this Policy by every Authorized User and by every person who accesses the Platform through credentials Customer controls, whether or not Customer authorized that access. An act by an Authorized User that would breach this Policy if taken by Customer is a breach by Customer.

2. General Obligations

Customer and each Authorized User will use the Platform only for the Permitted Use, only at the Licensed Locations, only within the entitlements and Usage Limits the Order Form states, and in compliance with all Applicable Law and with the Master Agreement.

3. Prohibited Content

You will not submit, store, transmit, publish, or make available through the Platform any material that:

(a) is unlawful, defamatory, libelous, harassing, threatening, abusive, obscene, sexually explicit, discriminatory, or that incites violence or harm;

(b) infringes or misappropriates any patent, copyright, trademark, trade secret, right of publicity, moral right, or other right of any person, or that you do not hold the rights to submit;

(c) contains any virus, worm, trojan, ransomware, keylogger, or other malicious or harmful code;

(d) contains the confidential information of any third party, including a former employer, that you are not authorized to disclose;

(e) contains information about any individual who is not a Patient or prospective patient of Customer, or about any person as to whom Customer lacks authority;

(f) concerns a person under eighteen, except as a Patient record a parent or guardian has authorized;

(g) includes a payment card number, Social Security number, government identification number, genetic information, or biometric identifier, except where an Order Form or the Documentation authorizes that category with specificity and the required consent has been obtained; or

(h) relates to a product, treatment, or service whose sale, promotion, prescribing, or dispensing at the Licensed Location is unlawful or outside the scope of practice of the Practitioner concerned.

4. Prohibited Conduct

You will not:

(a) use the Platform in violation of Applicable Law or of the rights of any person;

(b) impersonate any person, misrepresent your identity, your credentials, your role, or your authority to act for any person, or use a title, designation, or credential you do not hold;

(c) present any person who is not a Practitioner as making a clinical determination, or permit a person who is not a Practitioner to select, recommend, or approve a treatment;

(d) use urgency, pressure, a manufactured deadline, or a misleading scarcity claim to obtain a Patient’s agreement to a Treatment Plan, a purchase, or a financing application;

(e) offer, provide, solicit, or accept any commission, bonus, rebate, kickback, gift, or other thing of value to induce or reward a referral of a patient or of business, or engage in any arrangement prohibited by Anti-Kickback Laws;

(f) resell, sublicense, syndicate, rent, lend, or otherwise supply Platform content, in original or adapted form, to any other practice, business, organisation, or person, except as Section 12.3 of the Master Agreement permits;

(g) use the Platform in connection with any location that is not a Licensed Location, whether by remote access, shared credentials, aggregated reporting, or otherwise;

(h) interfere with or disrupt the Platform, its infrastructure, or another customer’s use of it, including by excessive automated requests, denial of service, or circumvention of any rate limit or usage control; or

(i) take any action that imposes an unreasonable or disproportionate load on the Platform or that degrades its performance for any other customer.

5. Security, Credentials, and Systems

You will:

(a) use only the individually assigned credential issued to you, and not share it with or permit its use by any other person, including a colleague;

(b) enroll in multifactor authentication where the Platform makes it available, and keep registered devices and contact details current;

(c) disable access within two business days for any person who ceases to be an Authorized User, and report any suspected credential compromise or lost device immediately;

(d) not copy, export, forward, download, photograph, screenshot, synchronize, or otherwise transfer Confidential Information or Customer Data to any personal device, personal email account, personal cloud storage, removable media, messaging application, or artificial intelligence tool or service not provided within the Platform;

(e) not attempt to gain unauthorized access to any system, account, tenant, or data, including that of another customer;

(f) not test, probe, scan, or benchmark the Platform for vulnerabilities, or conduct any penetration test or intrusive assessment, without Aesthetic Influence’s prior written authorization;

(g) not reverse engineer, decompile, disassemble, or attempt to derive the source code, architecture, models, or algorithms of the Platform; and

(h) not use any robot, spider, scraper, or other automated means to access the Platform other than through an interface Aesthetic Influence provides.

6. Protected Health Information and the Designated Perimeter

Aesthetic Influence designates in the Documentation which modules, features, and workflows are supported for the processing of Protected Health Information. Aesthetic Influence acts as a business associate wherever the Platform creates, receives, maintains, or transmits Protected Health Information for a Customer. It supports the processing of Protected Health Information only in the designated modules, and Section 10.4 of the Master Agreement states the consequences of submitting it elsewhere.

You will not submit Protected Health Information into any module, feature, or workflow that is not designated. In particular, you will not include Protected Health Information in a support ticket, a chat or email to support, a community or forum post, a feedback submission, an uploaded analysis document, or a marketing configuration.

Aesthetic Influence applies reasonable warnings, detection, blocking, and redaction controls to workflows identified as not supporting Protected Health Information. Those controls apply to the workflows so identified and not to every input field, automated detection cannot identify every form in which health information may be expressed, and no such control relieves you of responsibility for what you submit.

You will apply the minimum necessary standard in determining what to submit, and you will not submit data you are not authorized to submit.

7. Patient Communications and Consent

Customer is the sender of every Patient Communication transmitted through or in connection with the Platform, whatever sending display name is configured. You will:

(a) obtain and retain the consent Applicable Law requires for each recipient, each channel, and each purpose before sending, including prior express written consent where required for a text message or a call;

(b) record the wording, channel, scope, and date of each consent at the time it is obtained, and retain the record for the period Applicable Law requires;

(c) honor every opt out, revocation, and do not contact request promptly, across every channel and list, whether or not it uses a recognized keyword;

(d) scrub against applicable do not call registries and your own internal suppression list before sending;

(e) send no message outside the hours Applicable Law permits in the recipient’s own time zone, and include sender identification and opt out instructions in each message;

(f) not import or communicate with a contact obtained from a purchased list, from another practice, or from any source for which you do not hold the required consent; and

(g) not transmit Protected Health Information by an unsecured channel unless the Patient has been warned of the risk and has agreed in a manner Applicable Law permits.

Aesthetic Influence does not verify any consent record and does not determine whether a message is marketing or transactional. It may throttle, pause, or suspend messaging where a carrier, aggregator, or regulator requires it, where opt out or complaint rates exceed stated thresholds, or where it reasonably believes the consent basis is unreliable.

8. Claims, Representations, and Patient-Facing Material

You will not, in any Treatment Plan, proposal, presentation, patient education material, social media post, advertisement, or other communication produced through or derived from the Platform:

(a) make or facilitate any false, misleading, or unsubstantiated claim about a treatment, product, device, drug, result, credential, qualification, or price;

(b) state or imply any guarantee, warranty, or assurance of a clinical, financial, or operational outcome;

(c) present a result as typical where it is not, or use a testimonial or endorsement without disclosing any material connection the endorser has;

(d) describe a product or device inconsistently with its labeling or permitted use, or make a claim you do not hold substantiation for; or

(e) state or imply that Aesthetic Influence has approved, endorsed, supervised, verified, or accepted responsibility for any clinical, financial, or compliance decision, or attribute any published item to Aesthetic Influence.

Content Aesthetic Influence supplies, including templates, frameworks, scripts, creative examples, presentations, and educational material, is an illustrative starting point and is not approved copy. You are responsible for reviewing, adapting, and substantiating each item before use, for compliance with the advertising, solicitation, and professional conduct rules applicable in each State in which it is used, and for obtaining every manufacturer, brand, licensor, and other third party permission required.

9. Artificial Intelligence Features

You will accept the applicable in-product consent before using an AI Feature. You will treat every output as a draft requiring human review, and will ensure that a qualified human, and for clinical or patient facing output an appropriately licensed Practitioner, reviews and approves it before it is relied on, recorded, presented to a Patient, or acted on.

You will not: present any output as the work of a licensed professional or as a clinical determination; attribute an output to a named Practitioner who has not reviewed and adopted it; rename, relabel, or configure an AI Feature so that it states or implies the output is provided by a licensed person; use an output to substantiate a clinical, safety, or efficacy claim; or use an AI Feature to make or materially inform any decision concerning a Patient’s eligibility for treatment, pricing offered to a particular Patient based on inferred characteristics, or any other decision producing a legal or similarly significant effect on an individual.

10. Records, Pipeline, and Reporting Integrity

You will record accurately and completely any information you submit to Aesthetic Influence, and any activity this Agreement requires you to record in the Platform. You will not falsify, backdate, alter, inflate, omit, or delete any record, attendance entry, consent, signature, charting entry, or opportunity, will not record any activity, meeting, or commitment that did not occur as recorded, and will not misstate the status, value, probability, or terms of any opportunity or transaction.

Where a Guarantee applies, the records on which Guarantee compliance is measured must be accurate. Submitting inaccurate revenue, attendance, proposal, or event data in connection with a Guarantee is a breach of this Policy and of the Guarantee Rider.

11. The Member Community, Sessions, and Events

The member community, forums, group sessions, masterminds, benchmarking features, and events are provided for the exchange of general business experience. In any of them you will not:

(a) disclose Protected Health Information, Patient Media, or any information identifying a Patient;

(b) disclose another participant’s Confidential Information, or the commercial terms of any Order Form other than your own, which Section 20.3 of the Master Agreement makes confidential;

(c) post content that is unlawful, harassing, discriminatory, defamatory, or infringing;

(d) solicit participants for any product, service, program, or offering that competes with the Services, or use the community, member roster, directory, or any contact obtained through the Platform to market to participants;

(e) record, transcribe, screenshot, or redistribute any session, call, workshop, or community event without Aesthetic Influence’s prior written consent; or

(f) present any figure, result, or claim about your own practice that you know to be false.

12. Competitively Sensitive Information

Participants in the community are independent businesses that compete or may compete with one another. In any community, forum, session, mastermind, benchmarking feature, or event you will not disclose, solicit, or exchange your own or another participant’s current or future prices, price changes, discounts, package or membership pricing, margins, costs of goods, wages or compensation, capacity, or plans as to markets, territories, or patients. You will not enter into or invite any agreement, understanding, or coordinated course of conduct with another participant as to price, discount, output, capacity, territory, market or patient allocation, supplier selection, or the recruitment or compensation of personnel.

Discussion of your own past and general experience, of publicly available information, and of Aesthetic Influence’s own published pricing is not restricted. If a prohibited discussion begins, do not participate, leave the discussion, and report it under Section 15.

Aesthetic Influence does not review, moderate, or screen community content for compliance with competition law or any other law. Its provision of a benchmarking, comparison, or aggregate reporting feature is not an invitation to exchange competitively sensitive information, and any such feature draws only on De-Identified Data.

13. Competitive and Derivative Use

You will not access or use the Platform, or any content, template, framework, curriculum, script, or output obtained through it, in order to build, market, deliver, or support any program, curriculum, course, coaching, consulting, membership, or software offering that competes with the Services, or for the purpose of competitive analysis or benchmarking against Aesthetic Influence. Access by a competitor of Aesthetic Influence, or by a person conducting competitive analysis, is not permitted and any credential issued to such a person may be revoked immediately.

14. Third-Party Services and Integrations

Where you connect a Third-Party Service to the Platform, you authorize the disclosure of Customer Data to that provider as the integration requires, and you are responsible for that provider’s handling of the data and for executing any business associate agreement the provider requires. You will not connect any service that performs biometric identification on Customer Data without Aesthetic Influence’s prior written consent, and you will not configure any integration, destination, tag, or event that causes an impermissible disclosure of Protected Health Information or other Personal Information.

15. Reporting a Concern

Report a suspected breach of this Policy, a security concern, a suspected compromise, prohibited content, or a prohibited discussion to support@aestheticinfluence.co. Report a suspected security vulnerability to support@aestheticinfluence.co and do not test or exploit it. Aesthetic Influence will not retaliate against any person for a report made in good faith.

16. How We Enforce This Policy

Where Aesthetic Influence identifies conduct that breaches this Policy it may, in the order and combination it considers appropriate to the circumstances and in accordance with Section 9.6 of the Master Agreement: notify Customer and require remediation within a stated period; disable or restrict the specific feature, workflow, integration, message channel, content item, or User Account involved; remove or disable access to content; require completion of remediation or training as a condition of restoration; suspend access in accordance with Section 9.7; or terminate in accordance with Section 18.3.

Aesthetic Influence will use reasonable efforts to apply the least disruptive measure sufficient to address the risk. Where the breach presents a risk to the Platform, to Customer Data, to another customer, or to any person, or where Applicable Law or a third party requires it, Aesthetic Influence may act immediately and without prior notice. No exercise of a lesser measure waives the right to suspend or terminate.

Suspension does not relieve Customer of any payment obligation, does not extend any term, and does not entitle Customer to any credit or refund. During a suspension Aesthetic Influence will preserve Customer Data in accordance with Article 19 of the Master Agreement and will provide a reasonable means of obtaining Customer Data required for continuity of patient care on request.

17. No Duty to Monitor

Aesthetic Influence does not pre-screen, review, verify, validate, or approve Customer Data, Customer Materials, or community content, and assumes no duty to do so. It may remove or disable access to any item it determines to be unlawful, infringing, unsafe, in breach of this Policy, or otherwise unacceptable, in its discretion and without liability. No exercise or non-exercise of that right creates any duty to monitor, review, or remove anything else, and none is a representation that anything not removed is lawful, substantiated, consented to, or non-infringing. Section 12.8 of the Master Agreement applies.

18. Contact

Questions about this Policy may be sent to support@aestheticinfluence.co. Reports under Section 15 should be sent to support@aestheticinfluence.co.

This version is kept at /legal/2026-09-28/acceptable-use-policy. Earlier versions are available on request.